Haemonetics (HAE) Current Deferred Tax Assets (2010 - 2015)

Haemonetics has reported Current Deferred Tax Assets for 6 years, with the latest figure at $12.0 million in Q4 2015.

• On a quarterly basis, Current Deferred Tax Assets fell 25.83% year-over-year to $12.0 million in Q4 2015; TTM through Dec 2015 was $12.0 million, a 25.83% decrease from a year earlier, with the FY2015 full-year figure at $12.6 million, down 10.86% from the prior year.
• Current Deferred Tax Assets was $12.0 million for Q4 2015 at Haemonetics, roughly flat from $12.0 million in the prior quarter.
• The five-year high for Current Deferred Tax Assets was $16.2 million in Q4 2014, with the low at $9.5 million in Q4 2011.
• Average Current Deferred Tax Assets over 5 years is $12.3 million, with a median of $12.6 million recorded in 2015.
• The sharpest annual moves came in 2011 and 2013: Current Deferred Tax Assets declined 29.47% in 2011, then surged 42.6% in 2013.
• Over 5 years, Current Deferred Tax Assets stood at $9.5 million in 2011, then gained by 13.91% to $10.8 million in 2012, then jumped by 31.19% to $14.2 million in 2013, then increased by 14.06% to $16.2 million in 2014, then declined by 25.83% to $12.0 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $12.0 million (Q4 2015), $12.0 million (Q3 2015), and $12.7 million (Q2 2015), per Business Quant data.